Clin Microbiol Infect 2012; 18: E396–E400
Abstract
We conducted a nationwide retrospective study to evaluate clinical characteristics and outcome of mucormycosis among allogeneic haematopoietic stem cell transplant recipients. Twenty‐nine patients were diagnosed between 2003 and 2008. Mucormycosis occurred at a median of 225 days after allogeneic haematopoietic stem cell transplant, and as a breakthrough infection in 23 cases. Twenty‐six patients were receiving steroids, mainly for graft‐versus‐host disease treatment, while ten had experienced a prior post‐transplant invasive fungal infection. Twenty‐six patients received an antifungal treatment; surgery was performed in 12. Overall survival was 34% at 3 months and 17% at 1 year.